Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

67.05 USD -0.30 (-0.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Gilead Sciences

< Previous 1 2 3 4 5 6 7 8 9
...
79 80 Next >
Scientists Worldwide Feverishly Working to Develop New Drug and Vaccine Candidates for COVID-19 Crisis
Financialnewsmedia.com News Commentary 
From PR Newswire
Thinking about trading options or stock in Facebook, Gilead Sciences, Nvidia, Paypal, or Wells Fargo?
InvestorsObserver issues critical PriceWatch Alerts for FB, GILD, NVDA, PYPL, and WFC. 
From PR Newswire
Human Trials Forge Ahead For Development of COVID-19 Vaccine For Global Immunization
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Human Trials Forge Ahead For Development of COVID-19 Vaccine For Global Immunization
Financialnewsmedia.com News Commentary 
From PR Newswire
Gilead, Kite and oNKo-innate Announce Research Collaboration to Discover Cancer Immunotherapies Focused on Natural Killer (NK) Cells
Gilead Sciences, Inc. (Nasdaq: GILD), Kite, a Gilead Company, and oNKo-innate announced the companies have entered into a three-year cancer immunotherapy research collaboration to support discovery and... 
From Business Wire News Releases
Thinking about trading options or stock in Gilead Sciences, Coca-Cola, Square, Uber, or Exxon Mobil?
InvestorsObserver issues critical PriceWatch Alerts for GILD, KO, SQ, UBER, and XOM. 
From PR Newswire
Gilead Sciences to Release First Quarter 2020 Financial Results on Thursday, April 30, 2020
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2020 financial results will be released on Thursday, April 30, after the market closes. At 4:30 p.m. Eastern Time, Gilead’s... 
From Business Wire News Releases
Gilead Provides Additional Information Regarding 2020 Annual Meeting of Stockholders Due to COVID-19 Precautions
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that due to the COVID-19 pandemic and to support the health and safety of the company’s stockholders, employees, Board of Directors and surrounding... 
From Business Wire News Releases
Growing Number of Coronavirus Vaccines Under Development With 3 in Human Trials
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Growing Number of Coronavirus Vaccines Under Development With 3 in Human Trials
Financialnewsmedia.com News Commentary 
From PR Newswire
Thinking about trading options or stock in Advanced Micro Devices, Gilead Sciences, Netflix, United Airlines, or Uber?
InvestorsObserver issues critical PriceWatch Alerts for AMD, GILD, NFLX, UAL, and UBER. 
From PR Newswire
Data on 53 Patients Treated With Investigational Antiviral Remdesivir Through the Compassionate Use Program Published in New England Journal of Medicine
Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from a cohort analysis of 53 patients hospitalized with severe complications of COVID-19 who were treated with the investigational antiviral... 
From Business Wire News Releases
Gilead Announces $20 Million Philanthropic Fund to Support Nonprofit Organizations Impacted by the COVID-19 Crisis
Gilead Sciences, Inc. (Nasdaq: GILD) announced the creation of the global Gilead CARES (COVID-19 Acute Relief and Emergency Support) Grantee Fund to provide financial support to current grantees facing... 
From Business Wire News Releases
Biotechs Fast Track Repurposing Existing Drugs for COVID-19 Treatments
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Biotechs Fast Track Repurposing Existing Drugs for COVID-19 Treatments
Financialnewsmedia.com News Commentary 
From PR Newswire
FDA Accelerates Development of Novel Therapies for COVID-19
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
FDA Accelerates Development of Novel Therapies for COVID-19
Financialnewsmedia.com News Commentary 
From PR Newswire
Gilead Completes Acquisition of Forty Seven, Inc.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction for Toro Merger Sub, Inc., a wholly owned subsidiary of Gilead (“Purchaser”), to acquire... 
From Business Wire News Releases
Gilead Sciences and Second Genome Announce Strategic Collaboration in Biomarker and Inflammatory Bowel Disease Drug Discovery
Gilead Sciences, Inc. (Nasdaq: GILD) and Second Genome, a leader in microbiome science, today announced that the companies have entered into a four-year strategic collaboration to identify biomarkers... 
From Business Wire News Releases
Kite Licenses Antibodies and Establishes Collaboration With Teneobio in Multiple Myeloma
Kite, a Gilead Company (Nasdaq: GILD), and Teneobio, Inc. announced the companies have entered into a license and collaboration agreement through which Kite will receive exclusive rights to certain... 
From Business Wire News Releases
Thinking about trading options or stock in Costco, Gilead Sciences, Coca-Cola, Netflix, or Zoom Video Communications?
InvestorsObserver issues critical PriceWatch Alerts for COST, GILD, KO, NFLX, and ZM. 
From PR Newswire
Over 35 Companies In Race To Develop Vaccine For COVID-19 Health Crises
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Over 35 Companies in Race to Develop Vaccine for COVID-19 Health Crises
Financialnewsmedia.com News Commentary 
From PR Newswire
Gilead Announces Expiration of Hart-Scott-Rodino Waiting Period for Forty Seven Tender Offer
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to Gilead's cash tender offer... 
From Business Wire News Releases
WHO Officials Indicating At Least 20 Vaccines In Development In Global Race For A Cure
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
WHO Officials Indicating at Least 20 Vaccines in Development in Global Race for a Cure
Financialnewsmedia.com News Commentary 
From PR Newswire
Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisis
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisis
Financialnewsmedia.com News Commentary 
From PR Newswire
Thinking about buying stock in Gilead Sciences, Petmed Express, Tilray, Tonix Pharmaceuticals, or Wix.Com?
InvestorsObserver issues critical PriceWatch Alerts for GILD, PETS, TLRY, TNXP, and WIX. 
From PR Newswire
U.S. Food And Drug Administration Approves Epclusa® (Sofosbuvir/Velpatasvir) for Children Ages 6 and Older or Weighing at Least 17 kg with Chronic Hepatitis C Infection
Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Epclusa® (sofosbuvir 400mg/velpatasvir... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
79 80 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.